Summary of the UPICT protocol for 18F-FDG PET/CT imaging in oncology clinical trials

Journal of Nuclear Medicine

Volumn 56, Issue 6, 2015, Pages 955-961

  Graham, Michael M ^a   Wahl, Richard L ^b   Hoffman, John M ^c   Yap, Jeffrey T ^c   Sunderland, John J ^a   Boellaard, Ronald ^d   Perlman, Eric S ^e   Kinahan, Paul E ^f   Christian, Paul E ^c   Hoekstra, Otto S ^d   Dorfman, Gary S ^g  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Perlman Advisory Group LLC   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Fluorodeoxyglucose; Guideline; PET CT; Protocol

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); COMPUTED TOMOGRAPHY SCANNER; COMPUTER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; DIET; FLUID INTAKE; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; ONCOLOGY; OUTCOME ASSESSMENT; PET SCANNER; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; RADIATION SAFETY; RADIOCHEMISTRY; RISK MANAGEMENT; BREATHING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; METHODOLOGY; MOTION; MULTIMODAL IMAGING; NEOPLASM; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; RADIOGRAPHY; REPRODUCIBILITY; SCINTISCANNING; STANDARDS; TREATMENT OUTCOME;

CLINICAL TRIALS AS TOPIC; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MEDICAL ONCOLOGY; MOTION; MULTIMODAL IMAGING; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; RESPIRATION; RISK MANAGEMENT; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84930373084     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.115.158402     Document Type: Article

References (9)

1. UPICT template. http://qibawiki.rsna.org/index.php?title5UPICT-Template. Quantitative Imaging Biomarkers Alliance website. Accessed April 13, 2015.
2. Boellaard R, Delgado-Bolton R, Oyen WJ, et al. FDG PET/CT: EANM/SNMMI procedure guidelines for tumour PET/CT imaging-version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328-354.
3. Shankar LK, Hoffman JM, Bacharach S, et al. Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. J Nucl Med. 2006;47:1059-1066.
4. Boellaard R, O'Doherty MJ, Weber WA, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging-version 1.0. Eur J Nucl Med Mol Imaging. 2010;37:181-200.
5. QIBA profile: FDG-PET/CT as an imaging biomarker measuring response to cancer therapy (publicly reviewed version). http://rsna.org/uploadedFiles/ RSNA/Content/Science-and-Education/QIBA/QIBA-FDG-PET-Profile-v105 Publicly-Reviewed-Version-FINAL-11Dec2013.pdf. Radiological Society of North American website. Published December 11, 2013. Accessed April 13, 2015.
6. Boellaard R, Oyen WJ, Hoekstra CJ, et al. The Netherlands protocol for standardization and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging. 2008;35:2320-2333.
7. Fusion imaging: a new type of technologist for a new type of technology. J Nucl Med Technol. 2002;30:201-204.
8. Coleman RE, Delbeke D, Guiberteau MJ, et al. Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the Joint Working Group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. J Nucl Med. 2005;46:1225-1239.
9. Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50 (suppl 1):122S-150S.